Active Biotech AB (ACTI) - Cash Flow Conversion Efficiency

Latest as of September 2025: -1.600x

Based on the latest financial reports, Active Biotech AB (ACTI) has a cash flow conversion efficiency ratio of -1.600x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-7.20 Million ≈ $-774.83K USD) by net assets (Skr4.50 Million ≈ $484.27K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Active Biotech AB to measure how much of total assets are equity-financed.

Active Biotech AB - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Active Biotech AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check ACTI cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Active Biotech AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Active Biotech AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Bhageria Industries Limited NSE:BHAGERIA	0.048x
Exagen Inc NASDAQ:XGN	-0.722x
NextEye Co. Ltd KQ:137940	-0.144x
Polaryx Therapeutics, Inc. Common Stock NASDAQ:PLYX	-0.326x
Synchronoss Technologies Inc NASDAQ:SNCR	0.711x
Aluko Co Ltd KO:001780	0.068x
VenueG Co. Ltd KQ:019010	-0.005x
Social Commerce Partners Corporation Class A Ordinary Shares NASDAQ:SCPQ	N/A

Annual Cash Flow Conversion Efficiency for Active Biotech AB (2002–2024)

The table below shows the annual cash flow conversion efficiency of Active Biotech AB from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Active Biotech AB.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr32.07 Million ≈ $3.45 Million	Skr-40.40 Million ≈ $-4.35 Million	-1.260x	+15.54%
2023-12-31	Skr30.67 Million ≈ $3.30 Million	Skr-45.74 Million ≈ $-4.92 Million	-1.492x	+6.15%
2022-12-31	Skr34.51 Million ≈ $3.71 Million	Skr-54.85 Million ≈ $-5.90 Million	-1.589x	-60.68%
2021-12-31	Skr46.67 Million ≈ $5.02 Million	Skr-46.17 Million ≈ $-4.97 Million	-0.989x	+32.11%
2020-12-31	Skr22.11 Million ≈ $2.38 Million	Skr-32.22 Million ≈ $-3.47 Million	-1.457x	-118.79%
2019-12-31	Skr53.78 Million ≈ $5.79 Million	Skr-35.81 Million ≈ $-3.85 Million	-0.666x	-44.02%
2018-12-31	Skr87.92 Million ≈ $9.46 Million	Skr-40.65 Million ≈ $-4.37 Million	-0.462x	+22.68%
2017-12-31	Skr77.68 Million ≈ $8.36 Million	Skr-46.45 Million ≈ $-5.00 Million	-0.598x	-49.20%
2016-12-31	Skr182.56 Million ≈ $19.65 Million	Skr-73.16 Million ≈ $-7.87 Million	-0.401x	+66.78%
2015-12-31	Skr180.60 Million ≈ $19.44 Million	Skr-217.89 Million ≈ $-23.45 Million	-1.206x	-83.08%
2014-12-31	Skr405.31 Million ≈ $43.62 Million	Skr-267.09 Million ≈ $-28.74 Million	-0.659x	-161.28%
2013-12-31	Skr405.41 Million ≈ $43.63 Million	Skr-102.25 Million ≈ $-11.00 Million	-0.252x	+64.34%
2012-12-31	Skr339.92 Million ≈ $36.58 Million	Skr-240.40 Million ≈ $-25.87 Million	-0.707x	-655.82%
2011-12-31	Skr501.99 Million ≈ $54.02 Million	Skr-46.97 Million ≈ $-5.05 Million	-0.094x	+91.34%
2010-12-31	Skr181.76 Million ≈ $19.56 Million	Skr-196.32 Million ≈ $-21.13 Million	-1.080x	+9.35%
2009-12-31	Skr188.64 Million ≈ $20.30 Million	Skr-224.77 Million ≈ $-24.19 Million	-1.192x	-22.25%
2008-12-31	Skr163.61 Million ≈ $17.61 Million	Skr-159.46 Million ≈ $-17.16 Million	-0.975x	+1.04%
2007-12-31	Skr189.57 Million ≈ $20.40 Million	Skr-186.70 Million ≈ $-20.09 Million	-0.985x	+40.63%
2006-12-31	Skr60.36 Million ≈ $6.50 Million	Skr-100.13 Million ≈ $-10.78 Million	-1.659x	-52.37%
2005-12-31	Skr176.81 Million ≈ $19.03 Million	Skr-192.51 Million ≈ $-20.72 Million	-1.089x	-18.08%
2004-12-31	Skr162.30 Million ≈ $17.47 Million	Skr-149.65 Million ≈ $-16.10 Million	-0.922x	+7.56%
2003-12-31	Skr289.58 Million ≈ $31.16 Million	Skr-288.83 Million ≈ $-31.08 Million	-0.997x	-30.02%
2002-12-31	Skr380.27 Million ≈ $40.92 Million	Skr-291.71 Million ≈ $-31.39 Million	-0.767x	--

About Active Biotech AB

ST:ACTI Sweden Biotechnology

Market Cap

$1.50 Billion

Skr13.92 Billion SEK

Market Cap Rank

#19010 Global

#335 in Sweden

Share Price

Skr5.28

Change (1 day)

+2.33%

52-Week Range

Skr0.04 - Skr7.20

All Time High

Skr28.53